Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
Imran Afridi, MBBS, FACC*,
Paul A. Grayburn, MD, FACC*,
Julio A. Panza, MD, FACC
,
Jae K. Oh, MD, FACC
,
William A. Zoghbi, MD, FACC
and
Thomas H. Marwick, MD, FACC||
* Division of Cardiology University of Texas Southwestern Medical Center, Dallas, Texas, USA
Division of Cardiology, National Institutes of Health, Bethesda, Maryland, USA
Division of Cardiology, Mayo Clinic, Rochester, Minnesota, USA
Division of Cardiology, Baylor College of Medicine, Houston, Texas, USA
|| Division of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA

View larger version (14K):
[in a new window]
|
Figure 1 Comparison of Kaplan-Meier survival survival curves in the four patient groups.
|
|
Copyright © 1998 by the American College of Cardiology Foundation.